Factitious disorders
- Overview
- Theory
- Diagnosis
- Management
- Follow up
- Resources
Treatment algorithm
Please note that formulations/routes and doses may differ between drug names and brands, drug formularies, or locations. Treatment recommendations are specific to patient groups: see disclaimer
suspected factitious disorder
multi-disciplinary team management
Although it is best to identify one person as the primary provider to the patient, a multi-disciplinary team should be involved. This should include consulting ethics and legal services early.[25]Eastwood S, Bisson JI. Management of factitious disorders: a systematic review. Psychother Psychosom. 2008;77(4):209-18. http://www.ncbi.nlm.nih.gov/pubmed/18418027?tool=bestpractice.com Psychiatric evaluation is warranted in most cases to assess for comorbid psychiatric illness and evaluate suicide risk.
treatment of objective findings
Treatment recommended for ALL patients in selected patient group
Objective findings induced by the patient, such as infection or hypoglycaemia, must be treated as medically indicated. To prevent a patient from sabotaging treatment, supervising the patient may be necessary during this initial therapy.
Risky interventions or diagnostic procedures, such as surgeries, should be avoided unless absolutely necessary. To the extent possible, treatments should be based on objective data rather than exclusively on patient report.
psychological therapy
Additional treatment recommended for SOME patients in selected patient group
Psychiatric evaluation is warranted in most cases to assess for comorbid psychiatric illness and evaluate suicide risk.
When addressing concerns about a diagnosis of factitious disorder with the patient, the discussion should be non-punitive and supportive, respecting the dignity of the patient. Many will leave the hospital against medical advice and will not be amenable to follow-up treatment.
For those who either admit to feigning illness or are open to treatment, the long-term strategy aims towards changing behaviour so that it does not recur.
Follow-up treatment with psychotherapy has been discussed in multiple case series and case reports but has not been studied prospectively.[25]Eastwood S, Bisson JI. Management of factitious disorders: a systematic review. Psychother Psychosom. 2008;77(4):209-18. http://www.ncbi.nlm.nih.gov/pubmed/18418027?tool=bestpractice.com Approaches have included psychoanalytic psychotherapy, cognitive behavioural therapy, and supportive therapy in both inpatient and outpatient settings, sometimes augmented with medications. Although case reports have documented some treatment success with therapy, most patients are unlikely to engage in treatment. Some authors have suggested the establishment of centralised reporting registries to aid in the development of evidence-based treatments.[25]Eastwood S, Bisson JI. Management of factitious disorders: a systematic review. Psychother Psychosom. 2008;77(4):209-18. http://www.ncbi.nlm.nih.gov/pubmed/18418027?tool=bestpractice.com
This approach must be balanced with respect for protected health information and relevant laws.
safety measures + report to appropriate authorities
Treatment recommended for ALL patients in selected patient group
It is essential to remember that these cases are instances of abuse and must be reported to the appropriate authorities, such as child protective services, adult protective services, or the police.[26]Royal College of Paediatrics and Child Health. Perplexing presentations (PP)/Fabricated or induced Iilness (FII) in children – guidance. Mar 2021 [internet publication]. https://childprotection.rcpch.ac.uk/resources/perplexing-presentations-and-fii The institution's risk-management department or attorney should be consulted to help guide reporting and documentation.
The main concern is the safety of the people involved.[26]Royal College of Paediatrics and Child Health. Perplexing presentations (PP)/Fabricated or induced Iilness (FII) in children – guidance. Mar 2021 [internet publication]. https://childprotection.rcpch.ac.uk/resources/perplexing-presentations-and-fii
Choose a patient group to see our recommendations
Please note that formulations/routes and doses may differ between drug names and brands, drug formularies, or locations. Treatment recommendations are specific to patient groups. See disclaimer
Use of this content is subject to our disclaimer